Evaluation and Treatment of Diabetic Neuroarthropathy - Medical ...
Evaluation and Treatment of Diabetic Neuroarthropathy - Medical ... Evaluation and Treatment of Diabetic Neuroarthropathy - Medical ...
Evaluation & Treatment of Diabetic Neuroarthropathy Richard M Marks, M.D., FACS I have no professional conflicts associated with this lecture consultant: Biomet, Tornier
Objectives • discuss the musculoskeletal care of patients with diabetes mellitus • foot and ankle issues neuropathy ulceration Charcot neuroarthropathy amputation
- Page 1: Evaluation & Treatment of Diabetic
- Page 5 and 6: Diabetes; the “giving” disease
- Page 7 and 8: Diabetes mellitus Epidemiology >65
- Page 9 and 10: Neuropathy Epidemiology associated
- Page 11 and 12: Neuropathy metabolic contribution:
- Page 13 and 14: Neuropathy Autonomic dysfunction: a
- Page 15 and 16: Neuropathy Immune dysfunction: maln
- Page 17 and 18: Neuropathy treatment • maximize g
- Page 19 and 20: Diabetic foot ulcer Epidemiology 15
- Page 21: Ulcer formation pressure + neuropat
- Page 24 and 25: depth Ulcer classification 0: “at
- Page 26: Mechanical, structural factors •
- Page 30 and 31: Sensation Monofilament testing 5.07
- Page 32 and 33: Circulation Waveform characteristic
- Page 34 and 35: Infection • screening labs CBC, E
- Page 36 and 37: Infection
- Page 38 and 39: Healing potential Screening labs to
- Page 40 and 41: Off-loading • pressure prevents u
- Page 42 and 43: Total contact cast
- Page 44 and 45: Protection
- Page 46 and 47: Exostectomy
- Page 48 and 49: Exostectomy
- Page 50 and 51: Reconstruction
Objectives<br />
• discuss the musculoskeletal care <strong>of</strong><br />
patients with diabetes mellitus<br />
• foot <strong>and</strong> ankle issues<br />
neuropathy<br />
ulceration<br />
Charcot neuroarthropathy<br />
amputation
Change language